Key facts
- This page summarizes Michael Harsh's Form 4 filing for Compute Health Acquisition Corp..
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2023, 16:39.
Michael Harsh - 01 Aug 2023 Form 4 Insider Report for Compute Health Acquisition Corp.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2023, 16:39:05 UTC
- Prior SEC filing
- 01 Feb 2023
- Next SEC filing
- 23 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua Fink, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Harsh filed Form 4 for Compute Health Acquisition Corp. on 03 Aug 2023.
Change
- Previous filing in this sequence was filed on 01 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CPUH
transaction
Class A Common Stock
Award
- Transaction value
- Shares
- +21,120
- Change %
- +211%
- Price
- Shares after
- 31,120
- Date
- 01 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2
CPUH
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -31,120
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CPUH
transaction
Derivative
Class B Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -30,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Aug 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 30,000
- Exercise price
- Footnotes
- F1, F2, F4
CPUH
transaction
Derivative
Warrants
Disposed to Issuer
- Transaction value
- Shares
- -2,500
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Aug 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 2,500
- Exercise price
- $11.50
- Footnotes
- F1, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Michael Harsh is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 6 footnotes
Footnote F1
Reflects transactions in connection with that certain Business Combination Agreement (the "Business Combination Agreement"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) ("Allurion"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) ("Pubco") and the other parties thereto (the "Business Combination").
Footnote F2
Reflects the conversion of 30,000 shares of the issuer's Class B common stock, par value $0.0001 ("Class B Common Stock"), held by Mr. Harsh into 21,120 shares of the issuer's Class A common stock, $0.0001 par value ("Class A Common Stock"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, by and among the issuer, Compute Health Sponsor LLC, Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination.
Footnote F3
Pursuant to the terms of the Business Combination Agreement, each share of Class A Common Stock was canceled and converted into the right to receive 1.420455 shares of Pubco common stock, $0.0001 par value.
Footnote F4
As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading "Description of Securities--Founder Shares," the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date.
Footnote F5
Pursuant to the terms of that certain First Amendment to the Warrant Agreement, dated as of August 1, 2023, by and between the issuer and Continental Stock Transfer & Trust Company ("CST") and that certain Warrant Assignment, Assumption and Amendment Agreement, dated as of August 1, 2023, by and between the issuer and CST, each then-outstanding issuer public warrant acquired from the issuer was assumed by Pubco and converted into 0.6125 warrants to purchase 1.420455 shares of Pubco at an exercise price of $8.10 per whole share.
Footnote F6
These warrants become exercisable 30 days after the completion of the Business Combination and expire seven years after the completion of the Business Combination or earlier upon redemption or liquidation.